Cargando…
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
Autores principales: | Esteva, Andre, Feng, Jean, van der Wal, Douwe, Huang, Shih-Cheng, Simko, Jeffry P., DeVries, Sandy, Chen, Emmalyn, Schaeffer, Edward M., Morgan, Todd M., Sun, Yilun, Ghorbani, Amirata, Naik, Nikhil, Nathawani, Dhruv, Socher, Richard, Michalski, Jeff M., Roach, Mack, Pisansky, Thomas M., Monson, Jedidiah M., Naz, Farah, Wallace, James, Ferguson, Michelle J., Bahary, Jean-Paul, Zou, James, Lungren, Matthew, Yeung, Serena, Ross, Ashley E., Sandler, Howard M., Tran, Phuoc T., Spratt, Daniel E., Pugh, Stephanie, Feng, Felix Y., Mohamad, Osama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947124/ https://www.ncbi.nlm.nih.gov/pubmed/36813827 http://dx.doi.org/10.1038/s41746-023-00769-z |
Ejemplares similares
-
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
por: Esteva, Andre, et al.
Publicado: (2022) -
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
por: Spratt, Daniel E, et al.
Publicado: (2023) -
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent
Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
por: Feng, Felix Y., et al.
Publicado: (2021) -
Biological data annotation via a human-augmenting AI-based labeling system
por: van der Wal, Douwe, et al.
Publicado: (2021) -
A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer
por: Cario, Clinton L., et al.
Publicado: (2020)